Genes2Me Blog – CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems
Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical/Whole Exome
Liquid biopsy is a minimally invasive molecular testing approach that detects and analyzes cancer-derived biomarkers, such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other molecular components present in body fluids. Unlike conventional tissue biopsies, liquid biopsy provides genomic insights through a simple sample collection process, making it a valuable tool in modern cancer research and precision oncology.
With advancements in Next-Generation Sequencing (NGS) and molecular diagnostic technologies, liquid biopsy has become increasingly important for identifying genetic alterations, monitoring tumor evolution, assessing treatment response, and supporting personalized cancer management. NGS-based liquid biopsy approaches enable highly sensitive detection of clinically relevant genomic changes from low amounts of circulating DNA.
Liquid biopsy applications continue to expand across multiple cancer types, including breast, lung, and colorectal cancers. These technologies support researchers and healthcare professionals by providing deeper insights into tumor biology and cancer-associated genetic variations.
Through this Liquid Biopsy knowledge hub, explore educational articles covering ctDNA analysis, cancer biomarkers, NGS workflows, molecular oncology, and emerging innovations in non-invasive cancer diagnostics.
In oncology, timing is everything. Even with treatment improvements, many cancers are still being diagnosed too late for effective action. Early cancer diagnosis is a…
In the realm of cancer diagnosis and treatment, the advent of liquid biopsy has sparked a transformative shift. Liquid biopsy, a term encompassing the collection…